Do Peripheral Blood Inflammation Indices Differ Among Schizophrenia Patients with Clozapine Treatment? A cross-secfional investigation.
Öz
Background/Aims: There remains a need to investigate alternative pathophysiological processes in schizophrenia such as neuroinflammatory processes. We aimed to compare blood count levels, with a particular focus on peripheral blood inflammatory cell levels, among three distinct groups of participants: schizophrenia patients taking clozapine, schizophrenia patients taking antipsychotics other than clozapine, and healthy controls. We also evaluated the relationship between these findings and clinical characteristics.
Methods: The SC group included 47, the SA group included 61 patients and the HC group included 65 healthy controls. The neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and monocyte-lymphocyte ratio (MLR) were calculated by dividing the respective cell counts from white blood cell count (WBC). The relationship between these measures and clinical characteristics are done with the Positive and Negative Syndrome Scale (PANSS).
Results: WBC counts were significantly higher in the SC group than in the SA and HC groups. The log transformed NLR (LnNLR) was significantly higher in the SC group than the HC group and SA group, but there were no difference between the the SA and HC groups. LnNLR was significantly correlated with PANSS positive, general and total scores, but not significantly correlated with PANNS negative score. LnNLR was significantly different between groups after adjusting for age and gender using ANCOVA.
Conclusions: The current study sheds light on the potential immunological alterations associated with schizophrenia and its treatment with clozapine. The elevated NLR in individuals receiving clozapine treatment underscores the need for further research to elucidate the underlying mechanisms and clinical implications of this observation.
Anahtar Kelimeler
Schizophrenia, clozapine, inflammation, neutrophil-lymphocyte ratio
Etik Beyan
It was approved by the institutional ethics committee of Ankara Atatürk Sanatory Education and Research Hospital in accordance with the Declaration of Helsinki [Protocol No: 2023-2865].
Kaynakça
- 1. Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet 2022;399(10323):473-486.
- 2. Zamanpoor M. Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. Psychiatr Genet 2020;30(1):1-9.
- 3. Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E. Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics. Front Psychiatry 2019;9:753.
- 4. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009;460:753-757.
- 5. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu DH, et al. Common variants conferring risk of schizophrenia. Nature 2009;460:744-747.
- 6. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008;63:801-808.
- 7. Miller B, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011;70:663-671.
- 8. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102:5-14.
- 9. Karageorgiou V, Milas GP, Michopoulos I. Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis. Schizophr Res 2019;206:4-12.
- 10. Mazza MG, Lucchi S, Rossetti A, Clerici M. Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: A meta-analysis and systematic review. World J Biol Psychiatry 2020;21(5):326-338.